Next Science Limited is an Australia-based medical technology company. The Company’s...Next Science Limited is an Australia-based medical technology company. The Company’s primary focus is on the development and commercialization of its proprietary XBIO technology to reduce the impact of biofilm-based infections on human health. XBIO is a non-toxic technology with an efficacy in eradicating both biofilm-based and free-floating bacteria. The Company’s products include XPERIENCE, BLASTX, and Bactisure. The XPERIENCE product is designed for use in cleansing and removal of debris and microorganisms from wound sites. BLASTX Antimicrobial Wound Gel provides wound management by maintaining a moist wound environment, which is conducive to wound healing. The Bactisure Wound Lavage is used to remove debris, including microorganisms, from wounds using pulsed (jet) lavage. The Company operates in two geographic segments: North America and Australia and New Zealand.More
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.